Valuation: Clover Corporation Limited

Market Cap 15Cr 10Cr 8.98Cr 8.35Cr 7.66Cr 14Cr 984.19Cr 99Cr 39Cr 483.86Cr 38Cr 38Cr 1.67TCr P/E 2026 *
15x
P/E 2027 * 10.9x
Enterprise Value 14Cr 10Cr 8.83Cr 8.22Cr 7.54Cr 14Cr 968.7Cr 98Cr 38Cr 476.25Cr 38Cr 37Cr 1.65TCr EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.2x
Free-Float
76.93%
Yield 2026 *
-
Yield 2027 * -
1 day+1.73%
1 week+3.53%
Current month+4.14%
1 month-1.12%
3 months-12.00%
6 months+12.82%
Current year+11.39%
1 week 0.83
Extreme 0.83
0.89
1 month 0.7
Extreme 0.7
0.9
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.525
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
18/11/25 Buy

Chief Executive Officer

5,29,638 0.3171%
18/11/25 Sell

Chief Executive Officer

2,55,199 0.1528%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.73%+3.53%+67.62%-24.79% 10Cr
-6.33%+3.55%+33.95%+83.53% 1.44TCr
-4.43%-7.68%-29.17%+233.69% 793.78Cr
-3.29%-2.41%-17.16%-53.63% 248.05Cr
+0.39%+6.85%-76.00%-63.17% 150Cr
+0.76%-0.83%+20.34%-23.98% 122.33Cr
-2.40%-24.11%-51.12% - 120.53Cr
-3.36%-13.31%-32.21%-29.46% 123.18Cr
-0.54%-2.43%+18.77%+42.95% 120.97Cr
-0.58%-15.33%-68.66%-72.91% 91Cr
Average -1.80%-4.31%-13.36%+10.25% 321.93Cr
Weighted average by Cap. -4.38%-4.58%-0.27%+88.65%

Financials

2026 *2027 *
Net sales 9.4Cr 6.57Cr 5.77Cr 5.37Cr 4.93Cr 9.26Cr 633.03Cr 64Cr 25Cr 311.22Cr 25Cr 24Cr 1.08TCr 12Cr 8.12Cr 7.13Cr 6.63Cr 6.09Cr 11Cr 781.86Cr 79Cr 31Cr 384.39Cr 30Cr 30Cr 1.33TCr
Net income 98L 68.53L 60.19L 55.98L 51.37L 96.51L 66Cr 6.65Cr 2.6Cr 32Cr 2.57Cr 2.52Cr 112.18Cr 1.35Cr 94.41L 82.92L 77.11L 70.76L 1.33Cr 91Cr 9.16Cr 3.58Cr 45Cr 3.54Cr 3.47Cr 154.54Cr
Net Debt -23L -16.08L -14.13L -13.14L -12.06L -22.65L -15Cr -1.56Cr -60.95L -7.61Cr -60.38L -59.08L -26Cr -72L -50.35L -44.22L -41.13L -37.74L -70.91L -48Cr -4.88Cr -1.91Cr -24Cr -1.89Cr -1.85Cr -82Cr
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
24/26/24 A$0.8800 +1.73% 52,788
23/26/23 A$0.8650 -2.81% 1,63,339
22/26/22 A$0.8900 +2.30% 859
21/26/21 A$0.8700 +1.16% 13,224
20/26/20 A$0.8600 +0.58% 6,043
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8800AUD
Average target price
1.280AUD
Spread / Average Target
+45.45%

Annual profits - Rate of surprise